2016 ESC Guidelines for the diagnosis and treatment of acute and
CMR=cardiac magnetic resonance; COPD = chronic obstructive pulmonary disease; HF = heart failure; ICD = implantable cardioverter defibrillator; LV = left
2021 ESC Guidelines for the diagnosis and treatment of acute and
The content of these European Society of Cardiology (ESC) Guidelines has been published for 9.2 Multidisciplinary management of chronic heart failure .
TheManagement of Chronic and Acute Heart Failure: What Patients
27 Aug 2021 the longer European Society of Cardiology (ESC) Clinical Practice Guidelines for the diagnosis and treatment of acute and chronic heart ...
2016 ESC Guidelines for the diagnosis and treatment of acute and
The Task Force for the diagnosis and treatment of acute and chronic The content of these European Society of Cardiology (ESC) Guidelines has been ...
2016 ESC Guidelines for the diagnosis and treatment of acute and
20 May 2016 ESC GUIDELINES. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and ...
ESC Guidelines for the diagnosis and treatment of acute and chronic
19 May 2012 BNP ¼ B-type natriuretic peptide; CAD ¼ coronary artery disease; CMR ¼ cardiac magnetic resonance; COPD ¼ chronic obstructive pulmonary disease; ...
2014 ESC Guidelines on the diagnosis and treatment of aortic
Document covering acute and chronic aortic diseases of the thoracic The content of these European Society of Cardiology (ESC) Guidelines has been ...
2021 ESC Guidelines for the diagnosis and treatment of acute and
27 Aug 2021 Disclaimer: The ESC Guidelines represent the views of the ESC and were ... 9.2 Multidisciplinary management of chronic heart failure .
ESC Guidelines for the Diagnosis and Treatment of Acute Heart
ESC Guidelines on the Diagnosis and Treatment of Acute Heart Failure. Definitions and Aetiology. (1) Decompensation of chronic heart failure. (2) Acute
2016 ESC Guidelines for the diagnosis and treatment of acute and
HF ¼ heart failure; COPD ¼ chronic obstructive pulmonary disease; HFrEF ¼ heart failure with reduced ejection fraction; NSAIDs ¼ non-steroidal anti-inflammatory
